Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Germany gives final OK to AstraZeneca heart drug
Reuters
Thursday, December 15, 2011 - 10:59am
tags:
Germany, AstraZeneca, Brilinta
Pharma Gets More Time To Record Gifts To Docs
Pharmalot
Thursday, December 15, 2011 - 9:47am
tags:
physician gifts
Chelsea Therapeutics gets patent protection on hypotension drug
Reuters
Thursday, December 15, 2011 - 9:46am
tags:
Chelsea Therapeutics, hypotension, Northera, neurogenic orthostatic hypotension, Parkinson's Disease
Isis Adds Three New Drugs to Its Development Pipeline
Yahoo
Thursday, December 15, 2011 - 9:45am
tags:
Isis Pharmaceuticals, ISIS-FVIIRx, ISIS-DGAT2Rx, ISIS-APOARx, nonalcoholic steatohepatitis, thrombotic diseases, atherosclerosis
MAP's Levadex: Blockbuster Potential With A March 26 PDUFA Date
Seeking Alpha
Thursday, December 15, 2011 - 9:39am
tags:
Levadex, MAP Pharmaceuticals, FDA, migraines
Ampio Pharmaceuticals: The Unanswered Questions
Seeking Alpha
Thursday, December 15, 2011 - 9:38am
tags:
Ampio, Zertane, Optina, Ampion
Pfizer Settled About Half of Prempro Cases, Adds to Reserve
Bloomberg
Thursday, December 15, 2011 - 9:37am
tags:
Pfizer, settlements, Wyeth, Prempro, HRT
Fat-Burning Roche Medicine Stops Diabetes in Mice Study, Researchers Say
Bloomberg
Wednesday, December 14, 2011 - 6:44pm
tags:
Roche, diabetes, FGF21
Spectrum Turns Neglected Cancer Drugs Into Cash Cows
Investors.com
Wednesday, December 14, 2011 - 6:43pm
tags:
Spectrum Pharmaceuticals, cancer, Fusilev, Zevalin
BioSante’s Female Desire Drug Fails to Boost Libido in Late-Stage Studies
Bloomberg
Wednesday, December 14, 2011 - 6:41pm
tags:
BioSante, female sexual dysfunction, LibiGel
Alexza Pharmaceuticals: Forward Looking Approval Catalyst In Play
Seeking Alpha
Wednesday, December 14, 2011 - 4:26pm
tags:
Alexza, Adasuve, antipsychotics
Bristol-Myers and NeurOp extend deal through 2012
Yahoo/AP
Wednesday, December 14, 2011 - 1:04pm
tags:
Bristol-Myers Squibb, NeurOp, neuropathic pain
Salix submits FDA application for Crofelemer
CNBC
Wednesday, December 14, 2011 - 11:34am
tags:
FDA, Salix, Crofelemer, HIV-associated diarrhea
AZ, GSK ask carmakers for directions amid pharma breakdown
Fierce Pharma
Wednesday, December 14, 2011 - 11:24am
tags:
GSK, AstraZeneca
Why CytRx Corporation Is Still A Big Biotech 'If' Play
Seeking Alpha
Wednesday, December 14, 2011 - 11:22am
tags:
CytRx
Charles River Labs predicts 2012 earnings growth, more stability in new year
Yahoo/AP
Wednesday, December 14, 2011 - 11:20am
tags:
Charles River Laboratories
Threshold Pharma announces clinical trial results of Phase 1 TH-302 study
Yahoo/Fly on the Wall
Wednesday, December 14, 2011 - 11:18am
tags:
Threshold Pharmaceuticals, leukemia, TH-302
Eli Lilly ends agreement with TransPharma
Globes, Israel
Wednesday, December 14, 2011 - 11:16am
tags:
TransPharma, Eli Lilly, diabetes, ViaDor-PTH1-34
Novo Nordisk (NVO) Owns 55% Of All Insulin Sales With A Patent Stretching To 2022; This Makes Them A Top Pick In Healthcare For The Chairman of Dividend Growth Advisors
Yahoo/Wall St Transcript
Wednesday, December 14, 2011 - 11:02am
tags:
diabetes, insulin, Novo Nordisk
Why Pharmacyclics is seeing put selling
Yahoo/optionMONSTER
Wednesday, December 14, 2011 - 11:01am
tags:
Pharmacyclics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.